Biovision
26 March 2013 10:45
Lyon, France
GlySure
has been selected to present at the Biovision Investor
Conference. CEO Chris Jones will be presenting results from
recently completed trials of the companies' Continuous Blood
Glucose Monitoring system on Cardiac Surgery
patients.
Tuesday March 26th, 10:45 AM